Remote Monitored Systems PLC Update on new product development (0782D)
June 25 2021 - 2:00AM
UK Regulatory
TIDMRMS
RNS Number : 0782D
Remote Monitored Systems PLC
25 June 2021
25 June 2021
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has
been incorporated into UK law by the European Union (Withdrawal)
Act 2018. Upon the publication of this announcement via Regulatory
Information Service ('RIS'), this inside is now considered to be in
the public domain.
Remote Monitored Systems plc
("RMS" or the "Company")
Update on new product development
The Company is pleased to announce that the 5-ply version of its
Pro-Larva anti-viral mask, developed with Volz Filters UK Ltd
("Volz"), has been approved by the UK's Medicines and Healthcare
products Regulatory Agency ("MHRA"). The 5-ply mask has an
additional filter layer, produced by Volz, after the hydrophobic
outer layer, further strengthening the mask's already excellent
bacterial filter efficiency.
The last year has established a close working relationship
between Volz and the Company's subsidiary, Pharm 2 Farm Ltd
("P2F"). Not only is Volz manufacturing the existing 4-ply
anti-viral masks for P2F, but the two companies have also been
working on developing a new anti-viral filter material, as an
extension of the work on the anti-viral mask and covered by the
same patent. This new material has passed the proof-of-concept
stage and Volz and P2F are now looking at how this could be
commercialised (for example, in heating, ventilation and air
conditioning systems), although this is expected to take several
months, with work required on moving from proof-of-concept to large
scale production.
Antony Legge, Executive Chairman, said; "Volz have been an
excellent partner to Pharm 2 Farm, providing support in a number of
areas. We are delighted with the MHRA approval for the 5-ply mask
and to be working with Volz on an exciting development of the
<ALPHA>-virion technology, with the potential to incorporate
it into air filters."
- ENDS -
ENQUIRIES :
Remote Monitored Systems plc via IFC Advisory
Antony Legge (Executive Chairman)
SP Angel Corporate Finance LLP +44 20 3470 0470
Nominated Adviser and Joint Broker
Stuart Gledhill
Caroline Rowe
Peterhouse Capital Limited +44 20 7469 0930
Joint Broker
Lucy Williams
IFC Advisory Ltd +44 20 3934 6630
Graham Herring
Zach Cohen
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDFFFFIRIISFIL
(END) Dow Jones Newswires
June 25, 2021 02:00 ET (06:00 GMT)
Nanosynth (LSE:NNN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nanosynth (LSE:NNN)
Historical Stock Chart
From Sep 2023 to Sep 2024